Worldwide, approximately 1000 persons with HIV die from tuberculosis each day. Only a small proportion of those eligible to receive isoniazid are actually treated.
A patient experienced HIV-1 remission following allogeneic haematopoietic stem-cell transplantation (allo-HSCT) procedures using a donor with a homozygous mutation in the HIV co-receptor CCR5 (CCR5Δ32/Δ32).
Youth tolerate adult dose.
New option could be safer than F/TDF formulation.